CAS: 1401031-52-4 - N-(1-Methylethyl)-5-[2-(4-pyridinyl)ethynyl]-2-pyridinecarboxamide
Formula:C16H15N3O
InChI:InChI=1S/C16H15N3O/c1-12(2)19-16(20)15-6-5-14(11-18-15)4-3-13-7-9-17-10-8-13/h5-12H,1-2H3,(H,19,20)
InChI key:InChIKey=STAFRSGTRKNXHF-UHFFFAOYSA-N
SMILES:O=C(NC(C)C)C1=NC=C(C#CC=2C=CN=CC2)C=C1
- Synonyms:
- 2-Pyridinecarboxamide, N-(1-methylethyl)-5-[2-(4-pyridinyl)ethynyl]-
- LSN 2463359
- N-(1-Methylethyl)-5-[2-(4-pyridinyl)ethynyl]-2-pyridinecarboxamide
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
2-Pyridinecarboxamide, N-(1-methylethyl)-5-[2-(4-pyridinyl)ethynyl]- REF: IN-DA001C19CAS: 1401031-52-4 | 98% | To inquire | Thu 05 Dec 24 | |
LSN 2463359 REF: 3D-BGC03152CAS: 1401031-52-4 | Min. 95% | To inquire | Thu 16 Jan 25 | |
LSN2463359 REF: TM-T27854CAS: 1401031-52-4 | 99.36% | 35.00 €~1,336.00 € | Thu 23 Jan 25 |
2-Pyridinecarboxamide, N-(1-methylethyl)-5-[2-(4-pyridinyl)ethynyl]-
CAS:1401031-52-4
Formula:
C16H15N3O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
265.3098
Ref: IN-DA001C19
5mg | 191.00 € | ||
10mg | 301.00 € | ||
25mg | 595.00 € | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
LSN 2463359
CAS:1401031-52-4
LSN 2463359 is a novel, potent, and selective allosteric modulator of the metabotropic glutamate receptor. …
Formula:
C16H15N3O
Purity:
Min. 95%
Molecular weight:
265.31 g/mol
Ref: 3D-BGC03152
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 16 Jan 2025
LSN2463359
CAS:1401031-52-4
LSN2463359 is a positive allosteric modulators of the mGlu5 receptor.
Formula:
C16H15N3O
Purity:
99.36%
Color and Shape:
Solid
Molecular weight:
265.31
Ref: TM-T27854
2mg | 35.00 € | ||
5mg | 52.00 € | ||
10mg | 83.00 € | ||
25mg | 166.00 € | ||
50mg | 253.00 € | ||
100mg | 373.00 € | ||
200mg | 530.00 € | ||
1mL*10mM (DMSO) | 57.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025